The plasma concentration of resistin was also reduced, but only in the 129sve 5LO−/− T1D mice regardless of Cap treatment (5LO−/− vs 5LO−/− T1D p = 0.0022; 5LO−/− vs 5LO−/− T1D + Cap p = 0.0019; 5LO−/− + Cap vs 5LO−/− T1D p = 0.0015; 5LO−/− + Cap vs 5LO−/− T1D + Cap p = 0.0012), suggesting that in this case, resistin levels could be affected by LTs (Fig. 3E, F). Here, RETN is linked to type 1 diabetes mellitus.